Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Barbey

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Blood|September 8, 2001
Cardiac toxicity of arsenic trioxideJ T Barbey
Clinical Pharmacology and Therapeutics|March 2, 2012
Vardenafil-associated QTc changes: not merely a normal autonomic processJ T Barbey
Journal of Cardiovascular Pharmacology|January 1, 1991
Clinical pharmacology and beta-blocking efficacy of propafenoneJ T Barbey
Cardiology Clinics|May 1, 1997
Vasodepressor syncope. Diagnosis and managementJ T Barbey
Annals of Internal Medicine|November 6, 2001
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemiaJ T Barbey, S Soignet
JAMA|February 19, 1997
Loading dose of digoxinJ T Barbey, S R Donahue
The Journal of Clinical Psychiatry|October 24, 1998
SSRI safety in overdoseJ T Barbey, S P Roose
Pacing and Clinical Electrophysiology : PACE|November 1, 1992
A simple in vivo model to evaluate the effects of antiarrhythmic agentsA J Solomon, D Syn, J T Barbey
Pacing and Clinical Electrophysiology : PACE|September 1, 1988
Influence of ventricular fibrillation duration on defibrillation energy in dogs using bidirectional pulse dischargesD S Echt, J T Barbey, J N Black
The American Journal of Cardiology|January 2, 1990
Concentration/response relations for the multiple antiarrhythmic actions of sotalolR L Woosley, J T Barbey, T Wang, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Blood|September 8, 2001
Cardiac toxicity of arsenic trioxideJ T Barbey
Clinical Pharmacology and Therapeutics|March 2, 2012
Vardenafil-associated QTc changes: not merely a normal autonomic processJ T Barbey
Journal of Cardiovascular Pharmacology|January 1, 1991
Clinical pharmacology and beta-blocking efficacy of propafenoneJ T Barbey
Cardiology Clinics|May 1, 1997
Vasodepressor syncope. Diagnosis and managementJ T Barbey
Annals of Internal Medicine|November 6, 2001
Prolongation of the QT interval and ventricular tachycardia in patients treated with arsenic trioxide for acute promyelocytic leukemiaJ T Barbey, S Soignet
JAMA|February 19, 1997
Loading dose of digoxinJ T Barbey, S R Donahue
The Journal of Clinical Psychiatry|October 24, 1998
SSRI safety in overdoseJ T Barbey, S P Roose
Pacing and Clinical Electrophysiology : PACE|November 1, 1992
A simple in vivo model to evaluate the effects of antiarrhythmic agentsA J Solomon, D Syn, J T Barbey
Pacing and Clinical Electrophysiology : PACE|September 1, 1988
Influence of ventricular fibrillation duration on defibrillation energy in dogs using bidirectional pulse dischargesD S Echt, J T Barbey, J N Black
The American Journal of Cardiology|January 2, 1990
Concentration/response relations for the multiple antiarrhythmic actions of sotalolR L Woosley, J T Barbey, T Wang, et al.
Pageof 3